Sulfur Burps & Ozempic: GLP-1 Side Effects Explained

Last reviewed: June 3, 2026

Last updated: June 3, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

Yes, sulfur burps are a recognized gastrointestinal side effect of Ozempic and other GLP-1 receptor agonists, occurring in a subset of patients during the initial treatment phases. These burps result from slowed gastric emptying, which allows food to remain longer in the stomach and ferment, producing sulfur-containing gases.

For patients considering GLP-1 therapy—whether branded medications or compounded alternatives—understanding the full spectrum of potential GLP-1 effects is essential for informed decision-making. PlexusDx supports this conversation by combining clinical evidence with genetic insights into peptide pathway sensitivity, helping you and your provider anticipate individual response patterns.

How GLP-1 Medications Trigger Sulfur Burps

GLP-1 receptor agonists work by slowing gastric emptying—the rate at which food moves from the stomach into the small intestine. This slower transit allows undigested food and carbohydrates to ferment longer in the stomach, producing hydrogen sulfide and other volatile compounds that escape as sulfur-smelling burps or flatulence.

Delayed gastric emptying also shifts the composition of gut bacteria, favoring fermentation-prone species that generate sulfur compounds. This effect is dose-dependent; higher doses typically cause more pronounced gastrointestinal symptoms. Most patients report sulfur burps peak within 2–4 weeks of starting therapy, then gradually diminish as the body adapts.

Timeline and Prevalence of GLP-1 Gastrointestinal Side Effects

Gastrointestinal side effects from GLP-1 therapy are common but often temporary. Understanding the expected timeline and frequency helps distinguish normal adjustment from medication intolerance. Below is a clinical framework of gastrointestinal effects reported across GLP-1 clinical trials and real-world use.

Side Effect	Prevalence Range	Typical Timeline	Severity Pattern
Sulfur burps / rotten egg odor	15–28% of patients	Weeks 1–6, often improves by week 8	Mild to moderate; usually self-limiting
Nausea	40–50% of patients	Peaks weeks 1–4; resolves in 60–80% by week 12	Mild to moderate; dose-dependent
Constipation	20–30% of patients	Can persist beyond 12 weeks; requires intervention	Mild to severe; persistent management needed
Abdominal cramping	10–20% of patients	Weeks 1–3; typically resolves by week 6	Mild to moderate; often diet-responsive
Diarrhea	15–22% of patients	Variable onset; may emerge weeks 4–12	Mild to moderate; dietary adjustment helps

Why Individual Responses to GLP-1 Vary: Genetic and Biomarker Context

Not all patients experience sulfur burps or gastrointestinal side effects at the same intensity. Genetic variations in GLP-1 receptor sensitivity, glucose metabolism, and gut microbiome composition influence how aggressively the GLP-1 pathway responds, and therefore how pronounced initial gastrointestinal effects are.

PlexusDx's Precision Peptide Genetic Test examines key variants—including other pathway markers—that may help provide context for individual peptide pathway predispositions. Understanding whether you carry variants associated with heightened GLP-1 sensitivity can support a more informed conversation with your provider about dosing strategies, side effect management, and whether compounded or alternative GLP-1 options might suit your profile better.

Managing Sulfur Burps and Optimizing GLP-1 Tolerability

Practical strategies can reduce sulfur burps and other gastrointestinal discomfort. These include eating smaller, frequent meals; avoiding high-fat and heavily processed foods that ferment; staying well-hydrated; and increasing soluble fiber gradually to support healthy gut bacteria. Ginger, peppermint tea, and digestive enzymes may offer additional relief for some patients.

Dose timing matters too. Taking GLP-1 injections in the evening and eating a light dinner can minimize overnight fermentation. If sulfur burps persist beyond 6–8 weeks or significantly impact quality of life, discuss with your provider whether dose adjustment, medication type adjustment (for example, from injection to oral form), or temporary dose pausing is appropriate. PlexusDx compounded options offer flexibility in dosing commitment tiers—month-to-month, 3-month, and 6-month plans—allowing you to adjust your treatment pace without financial penalty as your tolerance evolves.

How PlexusDx Supports a More Personalized Approach

PlexusDx genetic insights may help provide context for your individual GLP-1 sensitivity profile before you start treatment. By understanding whether your genetic predispositions suggest higher or lower GLP-1 pathway activation, you and your provider can proactively plan dosing strategies and side effect mitigation—potentially reducing the intensity of early gastrointestinal symptoms like sulfur burps.

The Precision Peptide Genetic Test reveals predispositions in key peptide pathway variants (GIPR rs1800437, FTO rs9939609, MC4R rs17782313) that may influence how your body responds to GLP-1 activation. These results should be interpreted with a qualified healthcare provider—they help contextualize expected response patterns but do not predict exact medication response or guarantee freedom from side effects.

Using genetic predisposition data alongside clinical evidence supports a more personalized conversation with your provider about which GLP-1 formulation (injection or oral) and dosing commitment might align best with your tolerance profile and lifestyle. This informed approach is central to PlexusDx's precision-wellness model.

How Your Genetics Relate to GLP-1 Pathways

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, FTO rs9939609, and MC4R rs17782313 — relate to the biological pathways these medications act on. These are pathway-level associations only and do not predict how much weight you will lose or how you will respond to any specific medication. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights so you and your provider can see how your genes relate to these pathways. It does not recommend, prescribe, or determine which medication, dose, or peptide is right for you. The PlexusDx Precision Peptide Genetic Test ($298) gives you and your provider pathway-level genetic context to support a more personalized conversation. Genetics is a guide, not a guarantee.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers seven prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Tirzepatide Injection is $289/mo month-to-month, or from $249/mo on the 6-month plan. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $298 to personalize your protocol from day one.

Frequently Asked Questions

Why does slowed gastric emptying produce sulfur-smelling burps?

The article explains that GLP-1 receptor agonists slow the rate at which food leaves the stomach, so undigested food and carbohydrates ferment longer and release hydrogen sulfide and other volatile compounds. It adds that delayed emptying also shifts gut bacteria toward fermentation-prone species that generate sulfur compounds. The post describes the effect as dose-dependent.

When does the post say sulfur burps typically peak and settle?

The article says most patients see them peak within two to four weeks of starting therapy, then gradually diminish as the body adapts. Its side-effect table places the symptom in weeks one through six with improvement often by week eight, and describes it as mild to moderate and usually self-limiting. Persistence beyond six to eight weeks is flagged for a provider conversation.

Which side effect in the article's table is the one that may not resolve on its own?

Constipation. The table says it affects 20 to 30 percent of patients, can persist beyond twelve weeks, and requires intervention rather than resolving with time. That contrasts with nausea, cramping, and the sulfur burps themselves, which the table describes as peaking early and settling within weeks. The post treats persistent constipation as needing active management.

What food and drink changes does the article suggest for fermentation-related discomfort?

The post suggests smaller, more frequent meals, avoiding high-fat and heavily processed foods that ferment, staying well hydrated, and increasing soluble fiber gradually to support gut bacteria. It also mentions ginger, peppermint tea, and digestive enzymes as offering relief for some patients. These are dietary suggestions, and the article routes persistent symptoms back to a provider.

How reliable are the prevalence percentages in the article's side-effect table?

They should be read as approximations. The article presents ranges such as 15 to 28 percent for sulfur burps and 40 to 50 percent for nausea without naming the trials or datasets behind them, so the figures cannot be traced to a source from the post alone. The general pattern it describes, early gastrointestinal symptoms that usually ease, is better supported.

Related Reading

• Glp 1 Side Effects Plexusdx
• Ozempic Side Effects
• Mounjaro Side Effects Plexusdx
• Tirzepatide Vs Semaglutide Side Effects

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.